Aytu biopharma to report fiscal 2026 first quarter operational and financial results on november 13, 2025

Denver, co / access newswire / november 5, 2025 / aytu biopharma, inc. (the "company" or "aytu") (nasdaq:aytu), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results for its first quarter of fiscal 2026, after the market close on thursday, november 13, 2025. the company has scheduled a conference call and webcast that same day, thursday, november 13, 2025, at 4:30 p.m.
AYTU Ratings Summary
AYTU Quant Ranking